Stockscreener 앱 받기
147.61
0.57%
-0.8525
전일 마감가:
$148.46
열려 있는:
$148.96
하루 거래량:
2.00M
Relative Volume:
0.20
시가총액:
$364.08B
수익:
$65.51B
순이익/손실:
$8.93B
주가수익비율:
41.54
EPS:
3.5532
순현금흐름:
$14.12B
1주 성능:
-2.66%
1개월 성능:
+14.80%
6개월 성능:
+26.04%
1년 성능:
+74.46%
1일 변동 폭
$147.18
$149.41
1주일 범위
$146.28
$152.80
52주 변동 폭
$77.58
$156.92
머크앤드컴퍼니 Stock (MRK) Company Profile
명칭
Merck Co Inc
전화
908-740-4000
주소
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, NVS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
147.57 | 366.28B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,127.17 | 1.00T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
268.60 | 648.55B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
249.76 | 439.62B | 62.82B | 3.60B | 19.98B | 2.0274 |
NVS
Novartis Ag Adr
|
137.81 | 261.73B | 54.66B | 13.58B | 16.05B | 7.0171 |
머크앤드컴퍼니 Stock (MRK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-25 | 개시 | RBC Capital Mkts | Outperform |
| 2026-02-20 | 개시 | Barclays | Overweight |
| 2026-02-13 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-01-08 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | 개시 | Scotiabank | Sector Outperform |
| 2025-10-13 | 재개 | Citigroup | Neutral |
| 2025-09-17 | 다운그레이드 | Berenberg | Buy → Hold |
| 2025-05-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-04-22 | 개시 | Cantor Fitzgerald | Neutral |
| 2025-02-18 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-02-10 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-08 | 다운그레이드 | Truist | Buy → Hold |
| 2024-12-20 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | 재개 | BofA Securities | Buy |
| 2024-12-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-11 | 다운그레이드 | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | 개시 | Bernstein | Mkt Perform |
| 2024-03-11 | 다운그레이드 | Societe Generale | Hold → Sell |
| 2024-01-04 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Buy |
| 2023-10-27 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Hold |
| 2023-04-13 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-03-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | 개시 | Jefferies | Buy |
| 2023-02-22 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-11-18 | 개시 | Credit Suisse | Outperform |
| 2022-10-10 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-09-14 | 업그레이드 | Berenberg | Hold → Buy |
| 2022-07-06 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | 재개 | SVB Leerink | Outperform |
| 2022-04-06 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-12-17 | 개시 | Goldman | Buy |
| 2021-12-16 | 개시 | Daiwa Securities | Neutral |
| 2021-12-13 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-12-09 | 개시 | Wells Fargo | Overweight |
| 2021-12-07 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-11-29 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-11-01 | 업그레이드 | Argus | Hold → Buy |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | 재개 | Truist | Buy |
| 2021-05-20 | 다운그레이드 | Argus | Buy → Hold |
| 2021-04-07 | 재개 | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | 재개 | Bernstein | Outperform |
| 2020-09-29 | 개시 | Berenberg | Hold |
| 2020-08-03 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-06-12 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-01-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-16 | 개시 | SVB Leerink | Outperform |
| 2019-07-03 | 개시 | Mizuho | Buy |
| 2019-05-28 | 개시 | Goldman | Neutral |
| 2019-05-13 | 업그레이드 | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | 재확인 | Citigroup | Buy |
| 2018-10-09 | 재개 | Guggenheim | Buy |
| 2018-04-23 | 업그레이드 | Goldman | Neutral → Buy |
| 2018-04-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-03-12 | 업그레이드 | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-07 | 재확인 | Morgan Stanley | Equal-Weight |
| 2018-01-16 | 업그레이드 | SunTrust | Hold → Buy |
모두보기
머크앤드컴퍼니 주식(MRK)의 최신 뉴스
Merck & Co. stock gains as Guggenheim raises price target on oncology optimism - AD HOC NEWS
NewEdge Advisors LLC Purchases 41,950 Shares of Merck & Co., Inc. $MRK - MarketBeat
Baird Financial Group Inc. Sells 98,410 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
Merck & Co. stock heads into the open after a 1.0 percent drop - AD HOC NEWS
Allworth Financial LP Decreases Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock outperforms competitors despite losses on the day - MarketWatch
1 No-Brainer ETF I'm Loading Up on in 2026 and Beyond - The Motley Fool
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Guggenheim Analyst Says - MarketBeat
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell? - TradingView
Merck Animal Health Supports Next Generation of Bovine Veterinarians with $90,000 in Scholarships - American Ag Network
Guggenheim Adjusts Price Target on Merck & Co. to $170 From $146, Maintains Buy Rating - marketscreener.com
Merck's CEO and research chief will speak online Sept. 14 - Stock Titan
Merck to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Yahoo Finance
The Hashgraph Group, Merck, and PwC Germany Develop Solution for Cocoa Traceability and Digital Product Passports - marketscreener.com
Merck & Co. stock gains on Wells Fargo price target hike and cancer vaccine momentum - AD HOC NEWS
Weekly Recap: Intismeran win and Personalis 13% stake backs Tempus AI - TradingView
VIRGINIA RETIREMENT SYSTEMS ET Al Invests $79.56 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap - DirectorsTalk Interviews
California State Teachers Retirement System Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Amundi Has $1.59 Billion Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Saudi Central Bank - MarketBeat
NBH Bank Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Old Mission Investment Co LLC Makes New $1.34 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Oakmont Investment Advisors Inc. Invests $3.10 Million in Merck & Co., Inc. $MRK - MarketBeat
Three Seasons Wealth LLC Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Maloon Powers Pitre Higgins & Dennehy LLC Invests $882,000 in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock underperforms Friday when compared to competitors - MarketWatch
Merck & Co., Inc. (NYSE:MRK) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
NEOS Investment Management LLC Purchases 40,020 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by TD Waterhouse Canada Inc. - MarketBeat
Concurrent Investment Advisors LLC Has $36.09 Million Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Burford Brothers Inc. Sells 7,962 Shares of Merck & Co., Inc. $MRK - MarketBeat
India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar - reuters.com
Nykredit A S Takes $100.08 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Stock Holdings Decreased by Secure Asset Management LLC - MarketBeat
Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference - BioSpace
Nwam LLC Acquires 10,124 Shares of Merck & Co., Inc. $MRK - MarketBeat
Northwestern Mutual Wealth Management Co. Sells 40,376 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck (NYSE: MRK) digital chief holds stock units vesting through 2029 - Stock Titan
Proficio Capital Partners LLC Purchases 17,526 Shares of Merck & Co., Inc. $MRK - MarketBeat
Headlands Technologies LLC Makes New $1.41 Million Investment in Merck & Co., Inc. $MRK - MarketBeat
Susquehanna Fundamental Investments LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging - Yahoo Finance
Is Merck Stock Outperforming the Nasdaq? - finance.yahoo.com
Thornburg Investment Management Inc. Acquires 59,303 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Sold by Washington Trust Bank - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Benjamin Edwards Inc. - MarketBeat
Merck & Co., Inc. $MRK Shares Purchased by Alyeska Investment Group L.P. - MarketBeat
Van ECK Associates Corp Sells 422,266 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Inc (Derivatives) to Japanese Yen Price Today | Live MRK to JPY Converter & Exchange Rate - CryptoRank
머크앤드컴퍼니 (MRK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
1.30%
자본화:
|
볼륨(24시간):